Form 8-K - Current report:
SEC Accession No. 0000950170-25-088600
Filing Date
2025-06-23
Accepted
2025-06-20 17:39:16
Documents
10
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K apge-20250617.htm   iXBRL 8-K 81421
  Complete submission text file 0000950170-25-088600.txt   185316

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT apge-20250617.xsd EX-101.SCH 23918
12 EXTRACTED XBRL INSTANCE DOCUMENT apge-20250617_htm.xml XML 4546
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41740 | Film No.: 251062466
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)